Metabolic Syndrome: Can We Keep Check?

Area of Science:

• Endocrinology
• Cardiovascular Health
• Women's Health

Background:

• Metabolic syndrome (MetS) prevalence is increasing globally, largely driven by rising obesity rates.
• MetS significantly elevates the risk of developing atherosclerotic cardiovascular diseases and type II diabetes mellitus.

Purpose of the Study:

• To investigate and compare the prevalence of Metabolic Syndrome (MetS) and its individual components between premenopausal and postmenopausal women.
• To identify specific risk factors contributing to MetS in different menopausal stages.

Main Methods:

• A cross-sectional comparative study was conducted involving 1000 women (500 premenopausal, 500 postmenopausal) aged 40-65 years.
• Participants were assessed for MetS risk factors based on the NCEP ATP III criteria.
• Data was collected from patients attending the Obstetrics and Gynecology OPD from September 2012 to August 2014.

Main Results:

• Postmenopausal women exhibited a MetS prevalence of 48.6%, which is 1.7 times higher than the 27.4% observed in premenopausal women.
• Significant increases in hyperglycemia, hypertension, and hypertriglyceridemia were noted in postmenopausal women compared to their premenopausal counterparts.
• While central obesity and low HDL cholesterol were common in both groups, 5% of postmenopausal women presented with all five NCEP ATP III criteria, versus only 0.4% of premenopausal women.

Conclusions:

• Menopausal status is a critical factor influencing MetS prevalence, with postmenopausal women facing a substantially higher risk.
• Targeting premenopausal women for MetS risk assessment and intervention is essential for preventing future cardiovascular and metabolic morbidities.
• Proactive management strategies focused on premenopausal women can mitigate the long-term health consequences associated with Metabolic Syndrome.